Abstract

Drug Stability and Compatibility: Special Considerations for Home Health Care

Author(s): Lima Hetty A

Issue: Sep/Oct 1997 - Home Health Care

Page(s): 301-305

Download in electronic PDF format for $75

Abstract

The issue of determining and assigning extended drug-stability dating to compounded admixtures used in home care still continues to be problematic for many pharmacists. This article covers definitions of relevant terms, resources, ways drug containers affect stability, drug concentration issues, specific containers for small-volume parenterals, considerations for large-volume parenterals, special safety issues with total nutrient admixture solutions and product packaging and storage. Tables provide information regarding a sample drug stability/compatibility matrix and manufacturers of disposable elastomeric infusion devices. The author concludes that pharmacists must remember to always use sound professional judgment when determining compounded product expiration dates; and, if necessary, make reasonable extrapolations specific to an exact solution, concentration and container type that will be used.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Sep/Oct 1997 Pg. 301-305	Drug Stability and Compatibility: Special Considerations for Home Health Care Author(s): Lima Hetty A
Jan/Feb 2004 Pg. 10-14	Women's Oral Health: Is There a Hormonal Link? Author(s): Preckshot John
Jul/Aug 2011 Pg. 270-276	Home Infusion: Overview of the Infusion Patient-Care Process Author(s): Kennedy Steve
Sep/Oct 1997 Pg. 294-297	Home Infusion and Alternative-Site Health Care: The Big Picture Author(s): Lima Hetty A
May/Jun 2020 Pg. 242-245	Physicochemical Stability and Compatibility of Revefenacin (LAMA) and Formoterol Fumarate (LABA) Inhalation Solution Admixture Author(s): Ngim Kenley, Patel Jalpa
May/Jun 2011 Pg. 190-192	Drug Compatibility and Stability in Dextrose vs Saline Author(s): Newton David W
Jan/Feb 2002 Pg. 55-57	New Perspectives on Vancomycin Use in Home Care, Part 2: Delivery Systems Author(s): Kastango Eric S, Hadaway Lynn
Jul/Aug 2016 Pg. 328-332	Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures Author(s): Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace EdwardE
May/Jun 2013 Pg. 254-261	Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline Author(s): Klemmer Anja, Krämer Irene, Kamin Wolfgang
Nov/Dec 2020 Pg. 473-478	Intravenous Admixture Preparation Considerations, Part 7: Stability Issues Author(s): Allen Loyd V Jr
Jul/Aug 2002 Pg. 311-315	Compatibility Screening of Bivalirudin During Simulated Y-Site Administration with Other Drugs Author(s): Trissel Lawrence A, Saenz Christopher
Jan/Feb 2020 Pg. 44-50	Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 190-200	Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice Author(s): McNulty John P, Muller George
Mar/Apr 1999 Pg. 76-79	Men's Health: Practical Solutions to a Profoundly Underrated Health-Care Crisis Author(s): Milner Martin
Sep/Oct 2015 Pg. 432-436	In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers Author(s): Bhattacharya Sisir, Parekh Satish, Dedhiya Mahendra
Jan/Feb 2017 Pg. 66-75	Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate Author(s): Wu George, Yeung Stanley, Chen Frank
Jan/Feb 2017 Pg. 76-82	Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Author(s): Wu George, Yeung Stanley, Chen Frank
Nov/Dec 2022 Pg. 522-526	Intravenous Physical Compatibility of Heparin Sodium and Furosemide Author(s): Maktabi Briana, Howard Mitchell S, Baki Gabriella, Churchwell Mariann D
May/Jun 2016 Pg. 202-206	Does Your Drug Expertise Include Clinical Pharmaceutics? Author(s): Newton David W
Jan/Feb 2001 Pg. 69-73	Compatibility Screening of Hextend During Simulated Y-Site Administration with Other Drugs Author(s): Trissel Lawrence A, Williams Kimberly Y, Baker Ma